Poster: Pemvidutide Preserves Lean Body Mass During Weight Loss in Patients with Overweight and Obesity: Results of a Phase 2 MRI Based Body Composition Sub Study

Altimmune Inc. published this content on September 10, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2024 at 14:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]